We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Revolution Medicines Inc
2 own
4 watching
Current Price
$25.9
$-1.62
(-5.89%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,274.42M
52-Week High
31.37
52-Week Low
14.08
Average Volume
0.73M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,274.42M52-Week High31.3752-Week Low14.08Average Volume0.73MDividend Yield--P/E Ratio--What does the Revolution Medicines Inc do?
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
Read More
How much money does Revolution Medicines Inc make?
News & Events about Revolution Medicines Inc.
Market News Video
23days ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) touched a new 52-week high of 28.06/share. Thats a 99.29% rise, or 13.98 per share from the 52-week low of 14.08 set back on 05/12/2022...
Globe Newswire
1month ago
Findings Published in the Journal of Medicinal Chemistry Demonstrate Compounds Exceptional Selectivity for mTORC1 over mTORC2 Tumor Regressions Observed During Combination Treatment with a Bi-Steric mTORC1-Selective Inhibitor and a KRASG12C-Selective Inhibitor in Preclinical Lung Cancer Model that ...
Benzinga
1month ago
Latest Ratings for RVMD
DateFirmActionFromTo Mar 2022StifelUpgradesHoldBuy Nov 2021HC Wainwright & Co.MaintainsBuy Sep 2021StifelInitiates Coverage OnHold
View More Analyst Ratings for RVMD
View the Latest Analyst Ratings
read more...
Market News Video
5 months ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) crossed below their 200 day moving average of 22.46, changing hands as low as 22.34 per share. Revolution Medicines Inc shares are currently trading down about 2.1% on the day...
Globe Newswire
6 months ago
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the pricing of its underwritten public offering of 11,500,000 shares of common stock at a ...
Frequently Asked Questions
Frequently Asked Questions
What is Revolution Medicines Inc share price today?
Can Indians buy Revolution Medicines Inc shares?
How can I buy Revolution Medicines Inc shares from India?
Can Fractional shares of Revolution Medicines Inc be purchased?
What are the documents required to start investing in Revolution Medicines Inc stocks?
What is today’s traded volume of Revolution Medicines Inc?
What is today’s market capitalisation of Revolution Medicines Inc?
What is the 52-Week High and Low Range of Revolution Medicines Inc?
What percentage is Revolution Medicines Inc down from its 52-Week High?
What percentage is Revolution Medicines Inc up from its 52-Week Low?
Current Price
$25.9
$-1.62
(-5.89%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.